Stanford University
Showing 15,001-15,050 of 37,050 Results
-
Anjali Jotwani, MD, MS
Clinical Assistant Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioDr. Anjali Jotwani is an obstetrician and gynecologist at Stanford Health Care and a clinical assistant professor in the Department of Obstetrics & Gynecology, Division of Gynecology & Gynecologic Specialties at Stanford University School of Medicine.
Dr. Jotwani offers comprehensive obstetric and gynecologic care for patients at every stage of life, from adolescence to menopause. She specializes in obstetric care, preventive care, the perimenopause transition and menopause, and sexual health. Dr. Jotwani’s approach is rooted in trauma‑informed care and reproductive justice. She is committed to prioritizing patient perspectives, safety, and equity.
Dr. Jotwani’s research spans many areas, from the use of genetic testing during pregnancy, to factors that contribute to gynecologic cancers. Her research interests include obstetric trauma, postpartum wellness, and medical student and resident education. Dr. Jotwani has published her work in many peer-reviewed journals, including Fertility and Sterility, JAMA Oncology, and Cell. She has also delivered presentations at national conferences, including the annual meeting of the American Society for Reproductive Medicine.
Dr. Jotwani is a junior fellow of the American College of Obstetricians and Gynecologists and a member of the North American Menopause Society. -
Lydia-Marie Joubert
Staff Scientist, SLAC National Accelerator Laboratory
Current Role at StanfordDirector of Operations, Stanford SLAC Cryo-ET Center
Staff Scientist -
Andre Journel
The Donald and Donald M. Steel Professor of Earth Sciences, Emeritus
Current Research and Scholarly InterestsNon-parametric, non-Gaussian Geostatistics, Stochastic Simulation, Training image-based simulation
-
Israel Juarez Contreras
Postdoctoral Scholar, Biochemistry
BioI am a postdoctoral scholar in the lab of Rajat Rohatgi at Stanford University, where I study how membrane organization controls sterol accessibility and signaling. I earned my Ph.D. at UC San Diego with Itay Budin, where I uncovered how sterol structure and sphingolipid composition regulate membrane phase behavior in yeast and reconstituted systems. My current work translates these biophysical principles into disease-relevant contexts, with a focus on lysosomal lipid organization and sterol trafficking defects, including those associated with NPC1. Ultimately, I aim to establish an independent research program that defines how cells interpret membrane physical properties and how their dysregulation contributes to human disease.
-
Maria Juarez-Reyes
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Juarez-Reyes received her PhD in Health Psychology, MD and Internal Medicine residency training from the University of California at San Francisco. Her focus during medical training was in Behavioral Medicine. In 2010, she became board certified in Integrative Medicine through American Board of Integrative Holistic Medicine. She is currently a Clinical
Associate Professor in the Division of Primary Care and Population Health, Department of Medicine, Stanford University. She is currently the Director of Behavioral Health Group Medical Visits and serves as Site Director for Internal Medicine Residency program at Stanford. She developed “Beyond Stress”, a six-week group intervention for patients with stress, anxiety, and depression. This intervention has now been translated into Spanish, Mas Alla del Estres, and it is delivered to community based Spanish speaking cancer patients.
Her current research evaluates integrative behavioral health group medical visits and the relationship to anxiety, depression, burnout, and sleep in primary care and Spanish speaking community-based populations. Previous health disparities research includes tobacco cessation practices of community-based providers, breast cancer screening follow-up in Latinx women, Latinx adolescent reproductive behavior, medication eligibility criteria effects in ethnic subgroups, and TB treatment in urban county jails. She enjoys travel, walking with friends, anything science fiction and spending time with her family. -
Connie Juel
Professor of Education, Emerita
Current Research and Scholarly InterestsPoor Reading in Preterms: Neural Basis, Prediction, & Response to Intervention (with Heidi Feldman & Michal Ben Shachar). Five-year grant funded by NICHD, 2012-2017.
Effects of early elementary school instruction, and specific interventions, on literacy and language growth.
Longitudinal study of literacy development from preschool through first grade. Focus on classroom factors in 13 kindergarten and 13 first grade classrooms that affect growth across the years in children with different entering skill and language profiles. -
Riley Juenemann
Ph.D. Student in Computational and Mathematical Engineering, admitted Autumn 2021
BioThird-year Computational and Mathematical Engineering (ICME) PhD Candidate @ Stanford University passionate about research at the intersection of mathematics, computing, and biology.
-
Maximilian Julve
Clinical Assistant Professor, Medicine - Oncology
BioDr. Max Julve is a medical oncologist and Clinical Assistant Professor of Medicine (Oncology) at Stanford University School of Medicine, with a clinical and research focus in solid tumor cellular therapy and melanoma.
Dr. Julve completed his medical training at Barts and The Royal London School of Medicine in the United Kingdom, followed by internal medicine training at teaching hospitals across North and Central London. He was subsequently awarded a National Institute for Health and Care Research (NIHR) Academic Clinical Fellowship in Medical Oncology at Imperial College London. During this time, alongside his clinical training, he conducted translational research within the King’s College London Immunoengineering group, focusing on transcriptional optimization of CAR-T cell therapies.
Dr. Julve later completed advanced clinical fellowships in solid tumor cellular therapy and melanoma at The Royal Marsden Hospital, London, and earned an MD(Res) doctorate investigating the role of immunosuppressive granulocytes in patients receiving immunotherapy.
He is a clinical investigator specializing in melanoma, immuno-oncology, and solid tumor cellular therapy, with a particular emphasis on translating mechanistic insights from the laboratory into novel therapeutic strategies for patients.
